IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
It has been shown that Aβ inhibits long‐term potentiation (LTP) in the rat hippocampus and this is accompanied by an increase in hippocampal concentration of IL‐1β. Aβ also increases microglial activation, which is the likely cell source of IL‐1β. Because IL‐4 attenuates the effects of IL‐1β in hippocampus, and microglial activation is inhibited by minocycline, we assessed the ability of both IL‐4 and minocycline to modulate the effects of Aβ on LTP and IL‐1β concentration. Following treatment with Aβ, IL‐4 or minocycline, rats were assessed for their ability to sustain LTP in perforant path‐granule cell synapses. We report that the Aβ‐induced inhibition of LTP was associated with increases in expression of MHCII, JNK phosphorylation and IL‐1β concentration, and that these changes were attenuated by treatment of rats with IL‐4 and minocycline. We also report that Aβ‐induced increases in expression of MHCII and IL‐1β were similarly attenuated by IL‐4 and minocycline in glial cultures prepared from neonatal rats. These data suggest that glial cell activation and the consequent increase in IL‐1β concentration mediate the inhibitory effect of Aβ on LTP and indicate that IL‐4, by down‐regulating glial cell activation, antagonizes the effects of Aβ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 9×
“(2007) 101, 771–781 2007 The Authors sion as well as IFNc and IL-1b concentration in tissue prepared from animals treated with Ab alone and those treated with Ab and IL-4 combined (+++p < 0.001: ANOVA; Figs 1b and c).”
BackgroundInfluentialRetractedWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · cited 1×
“Minocycline is a second-generation tetracycline and is known to have anti-inflammatory effects independent of their anti-microbial activity (Yrjanheikki et al. 1998); it inhibits microglial activation (Ryu et al.”
BackgroundBlum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Ledeboer, A., Sloane, E. M., Milligan, E. D., Frank, M. G., Mahony, J. H., Maier, S. F., & Watkins, L. R. (2005) · Pain · doi:10.1016/j.pain.2005.02.009 · Cited by 677
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527 · cited 1×
“…shown that injection of amyloid-b (Ab) peptides into the brain inhibits long-term potentiation (LTP) in vivo (Walsh et al. 2002; Freir et al. 2003; Minogue et al. 2003; Klyubin et al. 2004) and in vitro (Saleshando and O’Connor 2000; Chen et al. 2002; Wang et al. 2002, 2004b; Freir et al. 2003).”
BackgroundWang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Cited by
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 877
Regulation of learning and memory by meningeal immunity: a key role for IL-4
Derecki, N. C., Cardani, A. N., Yang, C. H., Quinnies, K. M., Crihfield, A., Lynch, K. R., & Kipnis, J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091419 · Cited by 800
Review: microglia of the aged brain: primed to be activated and resistant to regulation
Norden, D. M., & Godbout, J. P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01306.x · Cited by 792
Role of Microglia in Neurotrauma
Loane, D. J., & Byrnes, K. R. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.002 · Cited by 657
Michelucci, A., Heurtaux, T., Grandbarbe, L., Morga, E., & Heuschling, P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.003 · Cited by 411
Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 394
Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383
“…reported that aging and/or A could decrease the neuronal expression of microglial inhibitory factors, such as CD200, fractalkine or neurotransmitters (Acetylcholine or noradrenaline) (Cardona et al., 2006; Chitnis et al., 2007; Heneka and O’Banion, 2007; Lyons et al., 2007a; Duan et al., 2008).”
BackgroundCui, G.-H., Guo, H.-D., Li, H., Zhai, Y., Gong, Z.-B., Wu, J., Liu, J.-S., Dong, Y.-R., Hou, S.-X., & Liu, J.-R. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0150-2 · Cited by 347
Function of microglia and macrophages in secondary damage after spinal cord injury
Ren, Y., Zhou, X., & He, X. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.143423 · Cited by 316
Baruch, K., Ron-Harel, N., Gal, H., Deczkowska, A., Shifrut, E., Ndifon, W., Mirlas-Neisberg, N., Cardon, M., Vaknin, I., Cahalon, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211270110 · Cited by 295
Neuronal Interleukin-4 as a Modulator of Microglial Pathways and Ischemic Brain Damage
Zhao, X., Wang, H., Sun, G., Zhang, J., Edwards, N. J., & Aronowski, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1685-15.2015 · Cited by 295
The multifaceted profile of activated microglia
Lynch, M. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8077-9 · Cited by 268
Self-citationLi, S., & Selkoe, D. J. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15007 · Cited by 263
Lyons, A., Downer, E. J., Crotty, S., Nolan, Y. M., Mills, K. H. G., & Lynch, M. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1781-07.2007 · Cited by 258
“Hippocampal tissue was homogenized, and neurons were lysed in lysis buffer as described previously (Lyons et al., 2007).”
BackgroundMethodResultInfluentialSelf-citationDistrutti, E., O’Reilly, J.-A., McDonald, C., Cipriani, S., Renga, B., Lynch, M. A., & Fiorucci, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106503 · Cited by 237
Self-citationKiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., & Ikezu, T. (2010) · The FASEB Journal · doi:10.1096/fj.10-155317 · Cited by 212
Fenn, A. M., Hall, J. C. E., Gensel, J. C., Popovich, P. G., & Godbout, J. P. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1146-14.2014 · Cited by 207
“In those studies, IL-4 increased arginase expression and reduced inflammatory mediators including IL-1 and TNF- (Kitamura et al., 2000; Butovsky et al., 2006; Lyons et al., 2007).”
BackgroundLyons, A., Lynch, A. M., Downer, E. J., Hanley, R., O’Sullivan, J. B., Smith, A., & Lynch, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06253.x · Cited by 202
“…fractalkine down-regulates microglial activation (Mizuno et al. 2003) and we have previously shown that microglial activation is increased with age (Griffin et al. 2006; Lyons et al. 2007b); in this study, we investigated whether fractalkine treatment might exert a beneficial effect in aged rats.”
BackgroundMethodInfluentialSelf-citationFenn, A. M., Henry, C. J., Huang, Y., Dugan, A., & Godbout, J. P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.003 · Cited by 198
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine
Lynch, M. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.868448 · Cited by 146
Self-citationAlzheimer’s Disease, Inflammation, and the Role of Antioxidants
Sinyor, B., Mineo, J., & Ochner, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200171 · Cited by 120
Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition
Chakrabarty, P., Tianbai, L., Herring, A., Ceballos-Diaz, C., Das, P., & Golde, T. E. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-36 · Cited by 116
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
Lynch, M. A. (2015) · Brain Research · doi:10.1016/j.brainres.2014.08.040 · Cited by 115
“…models of Alzheimer's disease (AD) has also been associated with increased expression of IL-1β (Gallagher et al., 2012; Gallagher et al., 2013; Kelly et al., 2013) while administration of Aβ, which inhibits LTP, increase hippocampal concentration of IL-1β (Clarke et al., 2007; Lyons et al., 2007).”
Self-citationLyons, A., McQuillan, K., Deighan, B. F., O’Reilly, J.-A., Downer, E. J., Murphy, A. C., Watson, M., Piazza, A., O’Connell, F., Griffin, R., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.05.060 · Cited by 98
“…characterized by microglial activation and increased production of pro-inflammatory mediators, have been reported in the brain of aged animals (Lynch et al., 2007; Lyons et al., 2007b) and in animal models of Alzheimer’s disease and Parkinson’s disease (Chen et al., 2005; McGeer and McGeer, 1998).”
BackgroundSelf-citationXu, M., Yan, T., Gong, G., Wu, B., He, B., Du, Y., Xiao, F., & Jia, Y. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.275 · Cited by 51
Metadata
- Authors
- Lyons, A., Griffin, R. J., Costelloe, C. E., Clarke, R. M., & Lynch, M. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-01-23
- Volume
- 101
- Issue
- 3
- Pages
- 771-781
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1742979798
- Cited by
- 129
- References
- 13
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.